346 related articles for article (PubMed ID: 16088769)
1. Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature.
Arkenau HT; Müssig O; Buhr T; Jend HH; Porschen R
Z Gastroenterol; 2005 Aug; 43(8):719-22. PubMed ID: 16088769
[TBL] [Abstract][Full Text] [Related]
2. [Severe microangiopathic hemolytic anemia as first manifestation of a CUP syndrome. Rapid hematologic remission under polychemotherapy].
Abdel Samie A; Sandritter B; Theilmann L
Med Klin (Munich); 2004 Mar; 99(3):148-53. PubMed ID: 15024487
[TBL] [Abstract][Full Text] [Related]
3. [Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Dempke W; von Poblozki A; Kellner O; Wolf HH; Schmoll HJ
Wien Klin Wochenschr; 2000 Dec; 112(24):1053-8. PubMed ID: 11204317
[TBL] [Abstract][Full Text] [Related]
4. Microangiopathic hemolytic anemia caused by a signet-ring cell carcinoma of the intrahepatic bile duct.
Younes R; Ponzo P; Marzano A
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):431-434. PubMed ID: 28927252
[TBL] [Abstract][Full Text] [Related]
5. Metastatic signet ring gastric adenocarcinoma presenting with microangiopathic hemolytic anemia.
Ali N; Kamran N; Adil S; Pervez S
Indian J Gastroenterol; 2007; 26(4):185-6. PubMed ID: 17986749
[TBL] [Abstract][Full Text] [Related]
6. Microangiopathic hemolytic anemia as the first manifestation of metastatic signet ring cell carcinoma of unknown origin: a case report and review of literature.
Shin SY; Park H; Chae SW; Woo HY
Korean J Lab Med; 2011 Jul; 31(3):157-61. PubMed ID: 21779188
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract][Full Text] [Related]
8. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study.
Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK
Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098
[TBL] [Abstract][Full Text] [Related]
9. [Mucin-producing signet ring cell carcinoma of stomach accompanied by microangiopathic hemolytic anemia and disseminated intravascular coagulation: a case report].
Tsuchiya Y; Ishibashi H; Ohtsuka T; Nagasawa K; Niho Y; Ide K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):477-81. PubMed ID: 2559010
[TBL] [Abstract][Full Text] [Related]
10. Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review.
Nordström B; Strang P
Anticancer Res; 1993; 13(5C):1845-9. PubMed ID: 8267391
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman.
Kadikoylu G; Barutca S; Tataroglu C; Kafkas S; Erpek H; Meydan N; Yavasoglu I; Bolaman Z
Transfus Apher Sci; 2010 Feb; 42(1):39-42. PubMed ID: 19926523
[TBL] [Abstract][Full Text] [Related]
12. [A case of breast metastasis of gastric cancer].
Hasegawa S; Yoshikawa T; Yoshida T; Osaragi T; Cho H; Tsuburaya A; Kobayashi O; Sairenji M
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1115-8. PubMed ID: 17637552
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated adenocarcinoma with signet-ring cells of the Vater's ampulla, without jaundice but with disseminated carcinomatosis.
Nabeshima S; Kishihara Y; Nabeshima A; Yamaga S; Kinjo M; Kashiwagi S; Hayashi J
Fukuoka Igaku Zasshi; 2003 Jul; 94(7):235-40. PubMed ID: 14509231
[TBL] [Abstract][Full Text] [Related]
14. [Microangiopathic hemolytic anemia associated with gastric cancer].
Kanou T; Nosou Y; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T; Miura K; Kuramoto J
Gan No Rinsho; 1986 Aug; 32(9):1029-34. PubMed ID: 3091884
[TBL] [Abstract][Full Text] [Related]
15. Colon and gastric metastases from a primary signet-ring cell carcinoma of the urinary bladder.
Morelli O; Castellani D; Asciutti S; Baldoni M; Familiari L; Nardi E; Morelli A; Clerici C
Dig Liver Dis; 2006 Aug; 38(8):609-11. PubMed ID: 16551516
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safe use of modified FOLFOX-6 for metastatic gastric cancer with signet ring cell components complicated by disseminated intravascular coagulation and diffuse bone marrow carcinomatosis.
Ferrand FR; Gontier E; Guymar S; Fagot T; Ceccaldi B; Malfuson JV; de Revel T
Onkologie; 2012; 35(3):118-20. PubMed ID: 22414976
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: A rare case report.
Candar O; Ekinci O; Merter M; Aslan M; Aras I
J Clin Apher; 2022 Dec; 37(6):606-610. PubMed ID: 36125111
[TBL] [Abstract][Full Text] [Related]
18. [Microangiopathic hemolytic anemia. A form of presentation of stomach neoplasm].
Oliveira A; Frazão A; Duarte PC; Nogueira B
Acta Med Port; 1998 Jun; 11(6):569-72. PubMed ID: 9773537
[TBL] [Abstract][Full Text] [Related]
19. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
20. Signet ring cell carcinoma's myelophthisis.
Pinheiro NC; Rodrigues J; Pereira J; Silva AM
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24623544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
